Anti-inflammatory therapeutics for the treatment of atherosclerosis.
about
Kruppel-like factor 15 is critical for vascular inflammationAnti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for AtherosclerosisThe outliers become a stampede as immunometabolism reaches a tipping pointGlucose metabolic trapping in mouse arteries: nonradioactive assay of atherosclerotic plaque inflammation applicable to drug discoveryPrevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.CD40L and Its Receptors in Atherothrombosis-An UpdateThe Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of AtherosclerosisLysophosphatidic acid in atherosclerotic diseasesEstablishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis.Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study.An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.The role of uridine adenosine tetraphosphate in the vascular system.Dihydroaustrasulfone Alcohol (WA-25) Impedes Macrophage Foam Cell Formation by Regulating the Transforming Growth Factor-β1 Pathway.EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells.Mechanisms of thrombosis in obesity.Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway.Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study.HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesCombined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis.Highly Selective Photothermal Therapy by a Phenoxylated-Dextran-Functionalized Smart Carbon Nanotube Platform.Anti-inflammatory effect and action mechanisms of traditional herbal formula Gamisoyo-san in RAW 264.7 macrophages.Folate receptor: a macrophage "achilles' heel"?Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosisAccelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditionsDigoxin reduces atherosclerosis in apolipoprotein E-deficient miceBiological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases.Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPKGinseng extracts restore high-glucose induced vascular dysfunctions by altering triglyceride metabolism and downregulation of atherosclerosis-related genes.Chemokines: established and novel targets in atherosclerosis.Regulation of the inflammatory response of vascular endothelial cells by EPAC1.Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker.The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities.Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010--present).Emerging anti-inflammatory drugs for atherosclerosis.Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?Integrin activation as an alternative treatment approach for inflammatory diseases.Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.
P2860
Q24321728-8528DC3D-32EC-4784-81D6-49B27DD0F668Q26825251-BEBCA605-5773-48D9-B165-EAE673DB59C2Q27005951-58F08F48-33D6-4E9B-B944-24CD81A7DF66Q28485353-78AB1100-CAE2-4C5D-84CC-03A01F17E713Q30357131-3C1A8868-2D8F-49AA-921D-F545474871C4Q30455490-10451BF6-6F19-430E-AE8B-3EB37BBE5480Q33613358-D81F1207-63EE-49EE-8684-1B491549F074Q33814059-188F7C00-8B5B-4048-9B74-C98DDA9478D3Q33838927-5E8D09AD-DFF2-4D4A-A2B6-74351405B873Q34273486-EA6C2097-1E17-4D6E-BB98-B0806B37F5DEQ34474800-9A5E5D77-EECD-450C-B597-E908B4E5D936Q34544570-13644313-B20F-41FA-B076-77D9EE5F0654Q35147533-E622DA49-E9B9-4FFB-A5D5-6F2820FE3DEDQ35504071-59C48435-840D-47A1-B82D-191DDA47F819Q35626888-2C311FBE-E507-4CBD-9D27-6555760A7E1DQ35649907-0FF4D7B5-8594-431A-B432-8D782A66C14FQ35653311-3AF49C9F-5A8E-4272-95C3-15F1EBD72010Q35691449-D369BB7B-5DEF-4C13-AEBA-7CC4CA498ADFQ35785185-A5C655FC-E6F8-439A-9C1F-767180AFD0C6Q35795262-A74B633B-E452-4236-BF25-15EFFC526B93Q35914754-C7C8366F-6912-43E9-872E-DE4FDA388EDBQ35974471-38F7A30D-D3E3-47DF-BD4F-A575F5FAD8C2Q36079200-7E04698B-E5AE-4C4A-BF7A-99B8088B36DAQ36366267-5D000FEB-9976-41A2-BAB7-498F1A1DF327Q36728741-6D39BBC5-064E-4A2F-96FB-DE089B4F0518Q36746012-93F6E6C6-401B-4195-8924-83E8BC4E5D65Q36797363-6F4C7871-EC07-4DA4-B847-05142C66BBC6Q36817578-FF961456-5D49-4263-A6DB-4580145B0860Q36848196-AB857639-210F-4134-BC58-755C786F14C2Q37002637-341689E4-95B5-4B97-9AEA-050A16CB0FA2Q37249857-020AF886-E6C2-45B8-AABD-45C7BB366105Q37950973-82EDC8E2-D5F6-4228-8ACA-DDB3FF7D67EFQ37965220-3E601D7A-FEFD-4581-B3D9-D3A29B6F030FQ37991749-E32BF56E-F6CB-4E6E-9CEA-DE8E65A4FDF2Q38021995-65BE2463-8C3F-432F-9B00-051E1D29335AQ38072094-9FEE0F8A-5B39-4F95-88BC-9348E34ACB71Q38106998-5812FE08-B451-4421-B3AB-A18A80604C08Q38678404-C40F522B-FA4B-435D-8935-F4395EB7DE01Q39018123-FAA94D60-F294-48E8-89A7-479489C06951Q39040956-F9324492-7B8E-4410-AB7F-DA25A6F9B2FD
P2860
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@en
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@nl
type
label
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@en
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@nl
prefLabel
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@en
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@nl
P2860
P356
P1476
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
@en
P2093
Israel F Charo
Rebecca Taub
P2860
P2888
P304
P356
10.1038/NRD3444
P577
2011-05-01T00:00:00Z